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Abstract Escherichia coli can cause serious infections in the
neonates and pregnant women. Although E. coli is widely
studied,E. coli lactose-negative (lac−) strains have been rarely
described before. So, the aim of this study was to compare lac
− and lactose-positive (lac+) E. coli strains in respect of anti-
microbial susceptibility and the frequency of virulence genes
(VGs). The study included 58 lac+ and 58 lac− E. coli strains
isolated from pregnant women and neonates. Culture and the
results of biochemical reactions were conducted for lac− and
lac+ E. coli identification and differentiation. Disc diffusion
test was performed to study the antimicrobial susceptibility of
the isolates, and PCRwas used to detect VGs. Resistance to at
least one of the tested antibiotics was found among 14
(25.9%) E. coli lac+ and in 26 (44.9%) E. coli lac− strains.
Both lac+ and lac− E. coli strains were mostly resistant to
ampicillin (22.4 and 39.7%) and ticarcillin (20.7 and
39.7%). None of the tested strains produced extended-
spectrum β-lactamases (ESBLs). Genes fimH, fimA, iutA,
sfa/foc, neuC, ibeA, and hlyF were detected, respectively, in
96.6, 82.8, 32.8, 24.1, 22.4, 12.1, and 6.9% of lac+ E. coli
strains and in 94.8, 86.2, 48.3, 19.0, 8.6, 8.6, and 1.7% of lac−
strains. The antimicrobial susceptibility and the pathogenic
potential of both tested groups of E. coli strains are similar.
Therefore, omitting E. coli lac− strains as a potential etiolog-
ical agent of infections may pose a threat to the health and life
of both mothers and neonates.
Introduction
Saprophytic Escherichia coli strains, colonizing the human
alimentary tract, perform the function of commensals. In the
case when those bacteria colonize the human organism be-
yond the alimentary tract, they become opportunistic patho-
gens (Tenaillon et al. 2010). Most often, E. coli strains can
cause urinary tract infections (UTIs) and intestinal infections,
both in children and in adults. In rarer cases, they are also
responsible for generalized infections such as bacteremia, sep-
sis, and meningitis in neonates (Korczak et al. 2005; Obata-
Yasuoka et al. 2002; Watt et al. 2003). An infection of a neo-
nate may occur during the birth, when the child is exposed to a
direct contact with bacteria present in the genital tract and
sometimes also with microorganisms derived from the gastro-
intestinal tract of the woman giving birth (Watt et al. 2003).
Colonization of the genital tract or anus of a pregnant woman
by E. coli strains may also lead to infection of a neonate by
ascending route. This infection happens most frequently as a
result of premature rupture of membranes. Microorganisms
from the lower part of the genital tract (vagina, uterine cervix)
get to the amniotic sac and infect the fetus (Newton 2005).
Also, UTIs occurring in pregnant women are serious threat to
the fetus (Barber et al. 2013). Asymptomatic bacteriuria is the
most often type of UTIs in pregnant women which, if not
treated, in 20.0–30.0% of cases may lead to pyelonephritis.
It may result in premature birth and developmental retardation
or fetus necrosis, as well as a fetus with low birth weight
(Janicka et al. 1997). Development of an infection largely
depends on immunity of the host organism and the pathoge-
nicity of the strain that causes it (Korczak et al. 2005).
Adhesins, capsular antigen K1, hemolysins, aerobactin, and
invasion protein IbeA play the essential role in the pathogen-
esis of infections caused by E. coli (Johnson 1991). Most
E. coli rods are biochemically active. Their most important
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traits are the ability to decompose tryptophan into indole and
to ferment lactose. However, in clinical material, the presence
of non-reactive E. coli strains may be indicated. Their identi-
fication is difficult due to low metabolic activity, including the
lack of the ability to lactose fermentation (Gadage et al. 2014).
Lactose-negative (lac−) strains of E. coli, just as lactose-
positive (lac+) strains, can have a number of virulence
factors (VFs) and exhibit antibiotic resistance, as well as in-
duce infections (Nicoletti et al. 1988). In the available refer-
ences, there is little information about E. coli lac− strains.
There are also no results of studies comparing these strains
with E. coli lac+. Accordingly, the aim of this study was to
investigate E. coli lac− strains isolated from pregnant women
and neonates in respect of antibiotic susceptibility, the ability
to produce the extended-spectrum β-lactamases (ESBLs), and
the frequency of genes encoding selected VFs. The obtained
data were compared with results obtained for E. coli lac+
strains.
Material and methods
Bacterial strains and its identification
The research material enclosed 116 genetically unrelated
E. coli strains (58 lac+ and 58 lac−) isolated from pregnant
women and neonates hospitalized at the Dr. Biziel University
Hospital No.2 in Bydgoszcz. E. coli lac+ strains from preg-
nant womenwere obtained from rectal swabs (n = 26), vaginal
swabs (n = 12), and urine (n = 8) and, in the case of neonates,
from nasal cavities (n = 10) and urine (n = 2). In turn, E. coli
lac− strains were isolated from rectal swabs (n = 52) and urine
(n = 1) of pregnant women and from nasal cavities (n = 4) and
urine (n = 1) of neonates.
E. coli species identification was based upon colony mor-
phology, the ability to ferment lactose on theMacConkey agar
(Becton Dickinson), and the results of biochemical reactions
obtained in the VITEK®2Compact (bioMérieux). E. coli lac+
and lac− strains were differentiated on the basis of colony
color on the MacConkey agar and the result of the Taxo
ONPG Disks test (Becton Dickinson).
Antimicrobial susceptibility testing and detection
of ESBLs
The susceptibility of E. coli strains to selected antibiotics was
assessed with the Kirby-Bauer disk-diffusion method on the
Mueller-Hinton agar (Becton Dickinson) according to the rec-
ommendations of the European Committee on Antimicrobial
Susceptibility Testing (EUCAST 2013). E. coli ATCC 25922
was used for quality-control purposes.
The production of ESBLs was assessed using the
double-disk synergy test (Jarlier et al. 1988). E. coli
ATCC 25922 (not producing ESBLs) and Klebsiella
pneumoniae ATCC 700603 (producing ESBLs) were used
as reference strains.
Detection of virulence genes
In order to detect VGs, isolation of DNA and multiplex PCR
reactions were performed. DNA from the tested E. coli strains
was isolated using the Genomic Mini ki t (A&A
Biotechnology). The presence of genes encoding the follow-
ing VFs: type 1 fimbriae (fimA and fimH), S and F1C fimbriae
(sfa/foc), antigen K1 (neuC), receptor for aerobactin (iutA),
and protein IbeA (ibeA), hemolysin HlyF (hlyF), was detected
with multiplex PCR, according to the authors’ methodology
described before by Kaczmarek et al. (2012). The E. coli
BEN2908 strain was used as positive control for the fimA,
fimH, neuC, hlyF, iutA, and ibeA genes and strain 536 for
sfa/foc. As a negative control, a reaction mixture without
DNAwas included in the experiment.
Statistical analysis
Statistical analysis of the results was carried out using the chi-
square test and Fisher exact test, at the significance level
α = 0.05. Calculations were made with the program
Statistica 10 PL (StatSoft, Poland).
Results
Antibiotic susceptibility analysis
It was indicated that E. coli strains, both lac+ and lac−,
were mostly resistant to ampicillin (22.4 and 39.7%) and
ticarcillin (20.7 and 39.7%). Moreover, in the group of
E. coli lac− strains, a high percentage of strains not sus-
ceptible to ticarcillin with clavulanic acid (19.0%) and
cotrimoxazole (10.3%) was determined. From 1.7 to
6.9% of E. coli lac+ and lac− strains were resistant to the
other tested antibiotics (Table 1). The statistically signifi-
cant differences between E. coli lac+ and lac− were found
in the resistance to ticarcillin (P < 0.05) and ticarcillin with
clavulanic acid (P < 0.05). A significantly higher percent-
age of strains resistant to these antibiotics was recorded in
the group of E. coli lac− strains.
None of the tested E. coli lac+ and lac− strains produced
ESBL.
Among the tested E. coli strains, 20 antimicrobial resis-
tance patterns were distinguished (Table 2). It was stated that
4 profiles (A–D) were common for both the tested groups of
E. coli, whereas 7 (E–K) were typical only for E. coli lac+
strains and 9 (L–U) of E. coli lac−. Profile A occurred statis-
tically significantly more frequently in E. coli lac+ (n = 43)
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than in E. coli lac− (n = 32) (P < 0.05) (Table 2). Among
profiles typical only for E. coli lac+, two strains belonged to
profile E and the other profiles (F–K) were represented by
single E. coli strains. However, among profiles determined
only for E. coli lac−, most isolates (n = 6) were classified to
profile L, in which a statistically significant difference was
indicated between E. coli lac+ and E. coli lac− strains
(P < 0.05) (Table 2).
Moreover, 8 out of 20 drug-susceptibility profiles were
represented also by E. coli strains intermediate to 1 (profiles
E, G, I, O, P) and 2 antibiotics (profiles F, H, K). A higher
percentage of antibiotic intermediate-susceptible strains was
observed among E. coli lac+ strains than in the case of E. coli
lac− strains (12.1 vs. 3.4%). One isolate ofE. coli lac+ showed
only an intermediate susceptibility to two tested antibiotics, at
the same time not being resistant to any of the tested drugs
(profile K) (Table 2).
Prevalence of VGs
It was stated that the most common virulence genes (VGs), in
E. coli lac+ and lac− strains, were fimH (96.6 and 94.8%,
respectively) and fimA (82.8 and 86.2%, respectively)
(Fig. 1). A considerable percentage of E. coli strains (32.8%
lac+ and 48.3% lac−) had the gene iutA.On the other hand, the
presence of genes sfa/foc, neuC, and ibeAwas found, respec-
tively, in 24.1, 22.4, and 12.1% of E. coli lac+ rods and in
19.0, 8.6, and 8.6% of lac−. The gene hlyF occurred the least
commonly among the tested isolates (6.9% of lac+ and 1.7%
of lac−). A statistically significant difference between the
compared groups of E. coli lac+ and lac− strains was observed
only in the case of the gene neuC (P < 0.05) (Fig. 1).
This study indicated that E. coli strains represented differ-
ent profiles of genes encoding VFs. In the tested populations,
20 profiles of VGs were identified, including 9 common for
E. coli lac+ and E. coli lac− strains as well as 8 typical only for
E. coli lac+ and 3 of E. coli lac− (Table 3). Profile II occurred
statistically significantly more frequently in E. coli lac−
(n = 16) than in E. coli lac+ (n = 5) (P < 0.05) (Table 3).
For E. coli lac+ strains, a statistically insignificant
(P > 0.05) but slightly positive correlation (r = 0.08) between
the number of antibiotics to which the tested strains were
resistant and the number of VGs which they had was showed
(Fig. 2). From this, it follows that there was a very weakly
drawn tendency to increase the virulence of strains along with
an increase in their antibiotic resistance. In contrast, for E. coli
lac− strains, a statistically insignificant (P > 0.05) but slightly
negative correlation (r = −0.03) was shown (Fig. 3).
Table 1 Comparison of the
antimicrobial susceptibility
between E. coli lac+ (n = 58) and
E. coli lac− strains (n = 58)
Antibiotic No. of E. coli lac+ No. of E. coli lac−
R (%) I (%) S (%) R (%) I (%) S (%)
AM 13 (22.4) 0 (0.0) 45 (77.6) 23 (39.7) 0 (0.0) 35 (60.3)
SAM 0 (0.0) 0 (0.0) 58 (100.0) 4 (6.9) 0 (0.0) 54 (93.1)
AMC 0 (0.0) 0 (0.0) 58 (100.0) 2 (3.4) 0 (0.0) 56 (96.6)
TIC 12 (20.7) 0 (0.0) 46 (79.3) 23 (39.7) 0 (0.0) 35 (60.3)
TIM 0 (0.0) 0 (0.0) 58 (100.0) 11 (19.0) 0 (0.0) 47 (81.0)
FOX 1 (1.7) 0 (0.0) 57 (98.3) 0 (0.0) 0 (0.0) 58 (100.0)
CXM 0 (0.0) 0 (0.0) 58 (100.0) 0 (0.0) 0 (0.0) 58 (100.0)
FEP 0 (0.0) 0 (0.0) 58 (100.0) 0 (0.0) 0 (0.0) 58 (100.0)
IPM 0 (0.0) 0 (0.0) 58 (100.0) 0 (0.0) 0 (0.0) 58 (100.0)
ATM 0 (0.0) 3 (5.2) 55 (94.8) 0 (0.0) 0 (0.0) 58 (100.0)
CIP 0 (0.0) 3 (5.2) 55 (94.8) 2 (3.4) 0 (0.0) 56 (96.6)
NOR 0 (0.0) 3 (5.2) 55 (94.8) 2 (3.4) 1 (1.7) 55 (94.8)
AN 0 (0.0) 0 (0.0) 58 (100.0) 0 (0.0) 0 (0.0) 58 (100.0)
GM 0 (0.0) 0 (0.0) 58 (100.0) 1 (1.7) 0 (0.0) 57 (98.3)
NN 0 (0.0) 1 (1.7) 57 (98.3) 0 (0.0) 1 (1.7) 57 (98.3)
TGC 0 (0.0) 0 (0.0) 58 (100.0) 0 (0.0) 0 (0.0) 58 (100.0)
C 1 (1.7) 0 (0.0) 57 (98.3) 2 (3.4) 0 (0.0) 56 (96.6)
SXT 3 (5.2) 0 (0.0) 55 (94.8) 6 (10.3) 0 (0.0) 52 (89.7)
Underlined value are differences remarkable although not statistically significant
R resistant, I intermediate, S susceptible, AM ampicillin, SAM ampicillin/sulbactam, AMC amoxicillin/clavulanic
acid, TIC ticarcillin, TIM ticarcillin/clavulanic acid, FOX cefoxitin, CXM cefuroxime, FEP cefepime, IPM
imipenem, ATM aztreonam,CIP ciprofloxacin,NOR norfloxacin, AN amikacin,GM gentamicin,NN tobramycin,
TGC tigecycline, C chloramphenicol, SXT trimethoprim/sulfamethoxazole
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Discussion
E. coli should be ranked into the most important bacterial
agents that can cause life-threatening infections in the perina-
tal period (Watt et al. 2003). These bacteria may be the cause
of meningitis in neonates (neonatal meningitis-associated
E. coli, NEMEC), bacteriemia and sepsis (sepsis-associated
E. coli, SEPEC), and urinary tract infections (uropathogenic
E. coli, UPEC) (Obata-Yasuoka et al. 2002; Watt et al. 2003;
Alemu et al. 2012).
The analysis of the drug-susceptibility profiles of patho-
genic bacterial strains enables the constant monitoring of their
resistance to antibiotics. However, difficulty results from the
fact that the authors most often do not report to which group
(lac+ or lac−) they classified the tested E. coli strains.
Therefore, when discussing the obtained present results, it is
impossible to state to which population of E. coli we refer.
Susceptibility of E. coli strains to semi-synthetic penicillins
is diverse in the world. In Poland (Janicka et al. 1997), Nigeria
(Poey et al. 2012), and Ethiopia (Alemu et al. 2012; Tadesse
et al. 2014), it was estimated that 80.8, 95.3, and 68.8–100%
of E. coli strains were resistant to ampicillin, respectively. A
lower percentage of E. coli strains resistant to ampicillin iso-
lated from the vagina and rectum of pregnant women (39.9%),
as well as those not pregnant (48.6%), was found by Hilbert
et al. (2009) and Villar et al. (2013) and in the present study
(31.0%). Moreover, in this study, a statistically significant
difference was indicated between E. coli lac+ and lac− strains
Table 2 Antimicrobial resistance
patterns in E. coli lac+ (n = 58)
and E. coli lac− (n = 58) strains
Profile Antibiotic(s) Total no. of
E. coli (%)
No. of E. coli
lac+ (%)






75 (64.7) 43 (37.1) 32 (27.6) 0.019
B R: AM, TIC 12 (10.3) 5 (4.3) 7 (6.0) 0.542
C R: AM, TIC, SXT 4 (3.4) 1 (0.9) 3 (2.6) 0.309
D R: C 2 (1.7) 1 (0.9) 1 (0.9) 1.000
E R: AM, TIC
I: CIP
2 (1.7) 2 (1.7) 0 (0.0) 0.154
F R: AM, TIC,SXT
I:CIP, NOR
1 (0.9) 1 (0.9) 0 (0.0) 0.315
G R: AM, TIC, SXT
I: NOR
1 (0.9) 1 (0.9) 0 (0.0) 0.315
H R: AM, TIC
I: ATM, NOR
1 (0.9) 1 (0.9) 0 (0.0) 0.315
I R: AM, TIC,
I: ATM
1 (0.9) 1 (0.9) 0 (0.0) 0.315
J R: AM, FOX 1 (0.9) 1 (0.9) 0 (0.0) 0.315
K I: ATM, NN 1 (0.9) 1 (0.9) 0 (0.0) 0.315
L R: AM, TIC, TIM 6 (5.2) 0 (0.0) 6 (5.2) 0.012
M R: AM, SAM, AMC, TIC, TIM 2 (1.7) 0 (0.0) 2 (1.7) 0.154
N R: AM, TIC, TIM, CIP, NOR,
C, SXT
1 (0.9) 0 (0.0) 1 (0.9) 0.315
O R: AM, TIC, GM, SXT
I: NN
1 (0.9) 0 (0.0) 1 (0.9) 0.315
P R: AM, TIC, TIM
I: NOR
1 (0.9) 0 (0.0) 1 (0.9) 0.315
R R: AM, SAM, TIC, TIM 1 (0.9) 0 (0.0) 1 (0.9) 0.315
S R: AM, SAM, TIC 1 (0.9) 0 (0.0) 1 (0.9) 0.315
T R: CIP, NOR 1 (0.9) 0 (0.0) 1 (0.9) 0.315
U R: SXT 1 (0.9) 0 (0.0) 1 (0.9) 0.315
Total 116 (100.0) 58 (50.0) 58 (50.0)
Bold values are differences statistically significant. Underlined value are differences remarkable although not
statistically significant
R resistant, I intermediate, AM ampicillin, SAM ampicillin/sulbactam, AMC amoxicillin/clavulanic acid, TIC
ticarcillin, TIM ticarcillin/clavulanic acid, FOX cefoxitin, CXM cefuroxime, FEP cefepime, IPM imipenem,
ATM aztreonam, CIP ciprofloxacin, NOR norfloxacin, AN amikacin, GM gentamicin, NN tobramycin, TGC
tigecycline, C chloramphenicol, SXT trimethoprim/sulfamethoxazole
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in resistance to ticarcillin (20.7 vs 39.7%). Also, a low per-
centage of E. coli strains resistant to penicillins with inhibitors
of beta-lactamases and cephalosporins were found in this
study. Significant differences between E. coli lac+ and lac−
strains were found only in the case of resistance to ticarcillin
with clavulanic acid (0.0 vs 19.0%). Similar results were also
obtained in the authors’ earlier study (Kaczmarek et al. 2011),
as well as in studies by other authors (Barcaite et al. 2012),
Table 3 Profiles of VGs in
E. coli lac+ (n = 58) and E. coli
lac− (n = 58) strains
Gene(s) Total no. of
E. coli (%)
No. of E. coli
lac+ (%)




I fimA, fimH 44 (37.9) 24 (20.7) 20 (17.2) 0.444
II fimA, fimH, iutA 21 (18.1) 5 (4.3) 16 (13.8) 0.008
III sfa/foc, fimA, fimH, iutA 9 (7.8) 3 (2.6) 6 (5.2) 0.298
IV fimH 8 (6.9) 4 (3.4) 4 (3.4) 1.000
V sfa/foc, fimA, fimH 5 (4.3) 3 (2.6) 2 (1.7) 0.648
VI neuC, sfa/foc, fimA, fimH,
ibeA
4 (3.4) 1 (0.9) 3 (2.6) 0.309
VII neuC, fimA, fimH, iutA 4 (3.4) 3 (2.6) 1 (0.9) 0.309
VIII neuC, fimH, iutA 3(2.6) 2 (1.7) 1 (0.9) 0.559
IX Lack of tested genes 3 (2.6) 2 (1.7) 1(0.9) 0.559
X neuC, sfa/foc, fimA, fimH,
hlyF, iutA, ibeA
2 (1.7) 2 (1.7) 0 (0.0) 0.154
XI neuC, sfa/foc, fimA, fimH,
ibeA, iutA
2 (1.7) 2 (1.7) 0 (0.0) 0.154
XII neuC, sfa/foc, fimA, fimH 2 (1.7) 2 (1.7) 0 (0.0) 0.154
XIII sfa/foc, fimA, fimH, ibeA 1 (0.9) 1 (0.9) 0 (0.0) 0.315
XIV fimA, fimH, hlyF, iutA 1 (0.9) 1 (0.9) 0 (0.0) 0.315
XV neuC, fimA, fimH 1 (0.9) 1 (0.9) 0 (0.0) 0.315
XVI fimH, hlyF, ibeA 1 (0.9) 1 (0.9) 0 (0.0) 0.315
XVII fimH, iutA 1 (0.9) 1 (0.9) 0 (0.0) 0.315
XVIII fimA, fimH, iutA, ibeA 2 (1.7) 0 (0.0) 2 (1.7) 0.154
XIX hlyF, iutA 1 (0.9) 0 (0.0) 1 (0.9) 0.315
XX iutA 1 (0.9) 0 (0.0) 1 (0.9) 0.315
Total 116 (100.0) 58 (50.0) 58 (50.0)
Bold values are differences statistically significant. Underlined values are differences remarkable although not
statistically significant
Fig. 1 Prevalence of VGs in
E. coli lac+ and E. coli lac−
strains
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irrespective of the fact if the strains were isolated from the
rectum, vagina, or urine of pregnant women.
In the presented study, all the E. coli lac+ and lac− strains
were susceptible to imipenem, amikacin, and tigecycline,
which was also indicated in several other centers in Poland
(Daniluk et al. 2008; Cisowska et al. 2001; Sobieszczańska
et al. 2003; Sękowska et al. 2009). All the tested E. coli lac−
strains and 94.8% of lac+ strains were also susceptible to
aztreonam. Similar results were recorded in the earlier studies
in Poland (Kaczmarek et al. 2011; Cisowska et al. 2001).
Moreover, a high percentage of E. coli strains from both
tested groups susceptible to ciprofloxacin, norfloxacin, genta-
micin, tobramycin, chloramphenicol, and trimethoprim/
sulfamethoxazole was observed in the present study. An
equally high percentage of strains susceptible to ciprofloxacin,
with no resistance to gentamicin and amikacin, was isolated
from neonates in Lithuania (98.3%) (Tamelienė et al. 2012). A
high percentage of strains susceptible to ciproflofloxacin and
aminoglycosides was also recorded in E. coli isolated from the
vagina and rectum of pregnant women (Barcaite et al. 2012).
Mehta et al. (2012) and Enayat et al. (2008) recorded a lower
percentage of E. coli strains susceptible to fluoroquinolones
and trimethoprim/sulfamethoxazole, respectively. Other au-
thors that used E. coli isolated from the vagina of pregnant
women reported almost 92% of the strains susceptible to
cotrimoxazole (Spaetgens et al. 2002).
Fig. 2 Correlation between
antibiotic resistance and number
of tested VGs for E. coli lac+
Fig. 3 Correlation between
antibiotic resistance and number
of tested VGs for E. coli lac−
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ESBLs producing E. coli strains are a serious therapeutic
and epidemiological problem (Lina et al. 2014). In this study,
none of the tested strains produced ESBLs. In the earlier study,
also, no strains producing those enzymes were detected in
E. coli isolated from pregnant women and neonates
(Kaczmarek et al. 2011). In contrast, Villar et al. (2013) found
the ability to produce ESBL enzymes in 5.4% ofE. coli strains
isolated from pregnant women.
The knowledge about etiological agents of an infection and
their resistance to drugs, as well as the identification of traits
responsible for the virulence of bacteria, is of the utmost im-
portance in predicting the clinical course of an infection. The
information about the virulence of the E. coli strain also facil-
itates making proper therapeutic decision.
In this study, in both groups of E. coli rods, more than 80% of
strains having the gene fimA encoding the major structural sub-
unit of type 1 fimbriae were identified. A similar result was
obtained in the authors’ earlier study (Kaczmarek et al. 2012),
as well as in the study by Micenková et al. (2014). On the other
hand, the presence of the gene fimH determining the biosynthesis
of the adhesin of those fimbriae was found in more than 90% of
all the tested E. coli strains in the present study. Similarly, other
authors indicated the presence of this gene among 90–100% of
strains collected both from pregnant (Obata-Yasuoka et al. 2002;
Poey et al. 2012; Al-Mayahie 2013) and not pregnant women
(Obata-Yasuoka et al. 2002; Al-Mayahie 2013).
S- and F1C/S-related fimbriae are encoding by the genes sfa
and foc, respectively (Juskova and Ciznar 1994). Watt et al.
(2003) and Al-Mayahie (2013) indicated the presence of genes
encoding S and F1C fimbriae in 48–60% of strains isolated
from the vagina of pregnant women. In this study, the frequen-
cy of the gene sfa/foc was lower and amounted to 24.1%
among E. coli lac+ strains and 19.0% among lac− strains.
In the presented study, the occurrence of the gene hlyF,
encoding hemolysin F, was found in only 4.3% of strains, and
it occurred more often in lac+ strains. In an earlier study, the
percentage of strains that had the gene hlyF was significantly
higher in E. coli K1 (28.4%), in comparison with the group of
bacteria without this antigen (6.0%) (Kaczmarek et al. 2012).
E. coli producing the K1 antigen are responsible for about
80% of cases of meningitis in neonates (Watt et al. 2003).
Moreover, they may be the cause of bacteremia, sepsis, and
UTIs, both in children and adults (Alemu et al. 2012). The
presence of the gene neuC, encoding the capsule K1, was
higher in strains isolated from neonates with meningitidis
(92%) (Ewers et al. 2007; Watt et al. 2003) than in strains
isolated from the vagina, rectum, or urine of pregnant women
(Watt et al. 2003). In the present study, E. coli lac+ strains had
significantly more often gene neuC (22.4%) in comparison
with the group of lac− strains (8.6%).
This study indicated the presence of the gene iutA,
encoding the aerobactin receptor, in more than 30% of the
tested E. coli lac+ strains and in almost 50% of E. coli lac−
strains. A similar result was obtained by Poey et al. (2012) and
Watt et al. (2003). In the study byObata-Yasuoka et al. (2002),
there were more often isolated strains having the gene-coding
aerobactin from non-pregnant women than from pregnant
ones.
Invasive protein IbeA takes part in the penetration ofE. coli
into brain microvascular endothelial cells. In the present study,
the gene ibeA occurred only in 12.1% of E. coli lac+ strains
and 8.6% of lac− strains, but none of the tested strains came
from blood. In the earlier work, a significantly higher frequen-
cy of this gene was indicated among E. coli K1 (35.8%) than
in strains without the capsule K1 (4.5%) (Kaczmarek et al.
2012).
E. coli rods may cause serious parenteral infections, and
they are particularly dangerous for pregnant women and neo-
nates. In the present study, it was indicated that there were
more strains resistant to at least one antibiotic in the group
of lac− isolates, and the frequency of genes encoding chosen
virulence factors was similar in both groups of strains. E. coli
lac+ and lac− strains had also common profiles of drug sus-
ceptibility and tested VGs. This may indicate their very sim-
ilar pathogenic potential.
Conclusion
It is essential to pay attention to the presence of lac− strains of
E. coli in clinical material in the course of diagnostic proce-
dures and to carry out their species identification. Omitting
E. coli lac− strains as a potential etiological agent of infections
may pose a threat to the health and life of both mothers and
newborn babies.
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